Skip to content

FIRST CHOICE HEALTHCARE SOLUTIONS, INC.: 10-Q filed 2025-11-12

What FIRST CHOICE HEALTHCARE SOLUTIONS, INC. reported in its quarterly report filed 2025-11-12 (fiscal Q3 2025): 33 published measures, 98 facts as tagged in accession 0001493152-25-021640.

This filing

Form
10-Q (quarterly report)
Filed
2025-11-12
Fiscal period
fiscal Q3 2025
Accession
0001493152-25-021640 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All FIRST CHOICE HEALTHCARE SOLUTIONS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-09-304,113,110USD
At 2024-12-314,511,002USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-09-3040,155,246USD
At 2024-12-3136,982,542USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-09-30-36,042,136USD
At 2025-06-30-34,555,789USD
At 2025-03-31-33,892,892USD
At 2024-12-31-32,471,540USD
At 2024-09-30-32,484,587USD
At 2024-06-30-31,644,170USD
At 2024-03-31-29,758,602USD
At 2023-12-31-28,530,052USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2025-09-302,430USD
At 2024-12-3119,915USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-1,462,888USD92
2025-01-01 to 2025-09-30-3,500,214USD273
2025-04-01 to 2025-06-30-639,436USD91
2025-01-01 to 2025-03-31-1,397,892USD90
2024-07-01 to 2024-09-30-817,207USD92
2024-01-01 to 2024-09-30-3,884,911USD274
2024-04-01 to 2024-06-30-1,862,361USD91
2024-01-01 to 2024-03-31-1,205,341USD91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-552,485USD273
2024-01-01 to 2024-09-30685,385USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2024-01-01 to 2024-09-301,638,987USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2025-01-01 to 2025-09-30525,000USD273
2024-01-01 to 2024-09-30942,500USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2025-01-01 to 2025-09-3010,000USD273
2024-01-01 to 2024-09-30-1,638,987USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-09-30-71,281,363USD
At 2024-12-31-67,781,149USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-07-01 to 2025-09-3032,958,288shares92
2025-01-01 to 2025-09-3032,958,288shares273
2024-07-01 to 2024-09-3032,958,288shares92
2024-01-01 to 2024-09-3032,958,288shares274

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-07-01 to 2025-09-3032,958,288shares92
2025-01-01 to 2025-09-3032,958,288shares273
2024-07-01 to 2024-09-3032,958,288shares92
2024-01-01 to 2024-09-3032,958,288shares274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-0.04USD/shares92
2025-01-01 to 2025-09-30-0.11USD/shares273
2024-07-01 to 2024-09-30-0.02USD/shares92
2024-01-01 to 2024-09-30-0.12USD/shares274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-0.04USD/shares92
2025-01-01 to 2025-09-30-0.11USD/shares273
2024-07-01 to 2024-09-30-0.02USD/shares92
2024-01-01 to 2024-09-30-0.12USD/shares274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2025-09-30150,653USD
At 2024-12-31222,816USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-621,164USD92
2025-01-01 to 2025-09-30-1,780,034USD273
2024-07-01 to 2024-09-30-449,953USD92
2024-01-01 to 2024-09-30-1,425,774USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-09-303,603USD
At 2024-12-3192,185USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2025-01-01 to 2025-09-302,143,153USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-09-3037,160,986USD
At 2024-12-3133,274,182USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2025-09-301,173USD
At 2024-12-3172,270USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-07-01 to 2025-09-30621,394USD92
2025-01-01 to 2025-09-301,785,720USD273
2024-07-01 to 2024-09-30419,998USD92
2024-01-01 to 2024-09-301,405,973USD274

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2025-07-01 to 2025-09-30230USD92
2025-01-01 to 2025-09-305,686USD273
2024-07-01 to 2024-09-30-29,955USD92
2024-01-01 to 2024-09-30-19,801USD274

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2025-07-01 to 2025-09-30475,778USD92
2025-01-01 to 2025-09-301,384,866USD273
2024-07-01 to 2024-09-30308,338USD92
2024-01-01 to 2024-09-301,075,158USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-09-3032,958,288shares
At 2024-12-3132,958,288shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2025-09-3035,206,268USD
At 2024-12-3135,276,650USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2025-09-303,445,332USD
At 2024-12-313,734,869USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2025-09-303,398,707USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-1,462,888USD92
2025-01-01 to 2025-09-30-3,500,214USD273
2024-07-01 to 2024-09-30-817,207USD92
2024-01-01 to 2024-09-30-3,884,911USD274

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-1,462,888USD92
2025-01-01 to 2025-09-30-3,500,214USD273
2024-07-01 to 2024-09-30-840,416USD92
2024-01-01 to 2024-09-30-3,954,535USD274

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2025-01-01 to 2025-09-3013,836USD273
2024-01-01 to 2024-09-3025,965USD274

Nonoperating interest expense

Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.

PeriodValueUnitDays
2025-07-01 to 2025-09-30841,724USD92
2025-01-01 to 2025-09-302,143,153USD273
2024-07-01 to 2024-09-30368,354USD92
2024-01-01 to 2024-09-302,464,387USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-841,724USD92
2025-01-01 to 2025-09-30-1,720,180USD273
2024-07-01 to 2024-09-30-367,254USD92
2024-01-01 to 2024-09-30-2,459,137USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2024-01-01 to 2024-09-30-41,661USD274

Inspect the source

Entity
FIRST CHOICE HEALTHCARE SOLUTIONS, INC. / CIK 0001416876
Captured
2026-09-20T08:02:33.993Z
SEC response SHA-256
23df1673c0ec69b174fcce0a4724e9b2b81b56930f98d7877ae323e793187e44

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001416876.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))